Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Peters

Showing results (641-650 of 685) with videos related to

Pageof 69
Sort By:
Frontiers in Nuclear Medicine|October 2, 2024
An Update to the Pilot Study of <sup>177</sup>Lu-PSMA in Low Volume Hormone-Sensitive Prostate CancerBastiaan M Privé, Constantijn H J Muselaers, Inge M van Oort, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2015
In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer ConsortiumD J A Lobbezoo, R J W van Kampen, A C Voogd, et al.
Diagnostic and Prognostic Research|April 4, 2023
A study protocol of external validation of eight COVID-19 prognostic models for predicting mortality risk in older populations in a hospital, primary care, and nursing home settingAnum Zahra, Kim Luijken, Evertine J Abbink, et al.
JMIR Mhealth and Uhealth|October 22, 2025
Bidirectional Associations Between Physical Activity, Sedentary Behavior, and Daily Symptoms in Patients With Chronic Obstructive Pulmonary Disease: Longitudinal Observational StudyBanchia Palmen, Zjala Ebadi, Maarten van Herck, et al.
Practical Radiation Oncology|July 28, 2022
Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice GuidelineLia M Halasz, Albert Attia, Lisa Bradfield, et al.
British Journal of Cancer|April 17, 2015
Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?D J A Lobbezoo, R J W van Kampen, A C Voogd, et al.
Clinical Breast Cancer|August 26, 2025
Receptor Discordance During the Treatment Course of Patients With Metastatic Breast Cancer: Results From the SONABRE RegistryKarlijn E P E Hermans, Sandra M E Geurts, Franchette Van den Berkmortel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2021
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I TrialIngo K Mellinghoff, Marta Penas-Prado, Katherine B Peters, et al.
JAMA Oncology|December 26, 2024
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A ReviewCraig Horbinski, David A Solomon, Rimas V Lukas, et al.
Journal of Clinical Epidemiology|February 4, 2024
External validation of six COVID-19 prognostic models for predicting mortality risk in older populations in a hospital, primary care, and nursing home settingAnum Zahra, Maarten van Smeden, Evertine J Abbink, et al.
Pageof 69

Showing results (641-650 of 685) with videos related to

Sort By:
Pageof 69
Frontiers in Nuclear Medicine|October 2, 2024
An Update to the Pilot Study of <sup>177</sup>Lu-PSMA in Low Volume Hormone-Sensitive Prostate CancerBastiaan M Privé, Constantijn H J Muselaers, Inge M van Oort, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2015
In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer ConsortiumD J A Lobbezoo, R J W van Kampen, A C Voogd, et al.
Diagnostic and Prognostic Research|April 4, 2023
A study protocol of external validation of eight COVID-19 prognostic models for predicting mortality risk in older populations in a hospital, primary care, and nursing home settingAnum Zahra, Kim Luijken, Evertine J Abbink, et al.
JMIR Mhealth and Uhealth|October 22, 2025
Bidirectional Associations Between Physical Activity, Sedentary Behavior, and Daily Symptoms in Patients With Chronic Obstructive Pulmonary Disease: Longitudinal Observational StudyBanchia Palmen, Zjala Ebadi, Maarten van Herck, et al.
Practical Radiation Oncology|July 28, 2022
Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice GuidelineLia M Halasz, Albert Attia, Lisa Bradfield, et al.
British Journal of Cancer|April 17, 2015
Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?D J A Lobbezoo, R J W van Kampen, A C Voogd, et al.
Clinical Breast Cancer|August 26, 2025
Receptor Discordance During the Treatment Course of Patients With Metastatic Breast Cancer: Results From the SONABRE RegistryKarlijn E P E Hermans, Sandra M E Geurts, Franchette Van den Berkmortel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2021
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I TrialIngo K Mellinghoff, Marta Penas-Prado, Katherine B Peters, et al.
JAMA Oncology|December 26, 2024
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A ReviewCraig Horbinski, David A Solomon, Rimas V Lukas, et al.
Journal of Clinical Epidemiology|February 4, 2024
External validation of six COVID-19 prognostic models for predicting mortality risk in older populations in a hospital, primary care, and nursing home settingAnum Zahra, Maarten van Smeden, Evertine J Abbink, et al.
Pageof 69